Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on brain & cognitive health. Browse all Brain & Cognitive Health education

Attention, focus, and impulse control are shaped in large part by dopamine signaling in the brain — and dopamine biology is strongly influenced by genetics. ADHD is one of the most heritable of the common neurodevelopmental conditions, with twin studies estimating heritability around 70 to 80 percent. That does not mean a single gene causes it or that genetics is destiny. It means understanding dopamine pathways offers real, pathway-level context about attention and focus.

The genetics of attention: a dopamine story

Focus depends on the prefrontal cortex having the right amount of dopamine at the right time — too little or too much both impair attention. Many of the genes most studied in ADHD research govern how dopamine is received, transported, and broken down. No single variant determines attention; instead, many small genetic influences add up alongside sleep, stress, environment, and development.

DRD4 and dopamine receptors

DRD4 encodes the dopamine D4 receptor. A well-known version of this gene, the 7-repeat allele of a variable region, has been associated in numerous studies with ADHD traits and novelty-seeking behavior. The 7-repeat form appears to respond less strongly to dopamine, which may affect how reward and attention circuits are tuned. It is a probabilistic association, not a diagnostic marker.

SLC6A3 (DAT1): clearing dopamine from the synapse

SLC6A3, also called DAT1, encodes the dopamine transporter that pulls dopamine back out of the synapse after it fires. A 10-repeat variant in this gene has been studied extensively in relation to ADHD. Because the transporter controls how long dopamine stays active, differences here influence the tempo of dopamine signaling that underlies sustained attention.

COMT and prefrontal focus

COMT (catechol-O-methyltransferase) breaks down dopamine in the prefrontal cortex. The Val158Met variant (rs4680) changes enzyme speed: the Val version clears dopamine faster, the Met version more slowly. Research on the "warrior/worrier" framework has explored how this affects stress-related cognition and executive function. COMT is a clear example of how one variant nudges a pathway without dictating an outcome.

What genetic testing can and cannot do for ADHD

This is important: genetic testing does not diagnose ADHD. ADHD is a clinical diagnosis made by a qualified professional based on history, behavior, and standardized criteria — not a DNA test. What pathway-level genetics can offer is education about the dopamine and neurotransmitter systems involved in attention. It is context for a conversation, never a substitute for evaluation, and it does not predict response to any medication.

The PlexusDx Precision Peptide Genetic Test explores 14 pathways, 49 peptides, 150+ genetic insights, including variants across neurotransmitter and cognitive pathways such as those involving COMT. It is an educational tool for understanding your biology — genetics is a guide, not a guarantee, and it does not diagnose, treat, or manage ADHD or any condition.

Supporting attention alongside your biology

Whatever your genotype, the fundamentals of attention support are consistent: consistent sleep, regular physical activity (which raises dopamine and supports executive function), structured routines, stress management, and limiting attention-fragmenting habits. If you or your child struggle with attention, the most important step is evaluation by a qualified healthcare provider who can consider the full clinical picture.

Frequently Asked Questions About Genetics and ADHD

Can a genetic test diagnose ADHD?

No. ADHD is diagnosed clinically by a qualified professional using behavioral history and standardized criteria, not by DNA. Genetic testing can provide educational context about dopamine-related pathways involving genes like DRD4, SLC6A3, and COMT, but it cannot confirm or rule out ADHD and should never replace a proper clinical evaluation.

Which genes are linked to attention and ADHD?

Research most consistently implicates dopamine-system genes: DRD4 (the D4 receptor), SLC6A3 or DAT1 (the dopamine transporter), and COMT (which breaks down dopamine in the prefrontal cortex). Each contributes a small, probabilistic influence. ADHD is highly polygenic, meaning many genes and environmental factors combine rather than one gene causing it.

Does genetic testing predict which ADHD medication will work?

No. The Precision Peptide Genetic Test analyzes pathway-level genetics for education and does not predict response to any medication. Choosing and adjusting any treatment is a decision for a qualified healthcare provider. The test tells you about your biology; it does not tell you what to put in your body.

If ADHD is genetic, can lifestyle still help focus?

Yes. Genetics sets a baseline for dopamine signaling, but sleep, exercise, structure, and stress management meaningfully influence attention regardless of genotype. Genetics is a guide, not a guarantee. For diagnosis and management, work with a qualified healthcare provider who can build a plan around your full clinical picture.

Curious about the neurotransmitter pathways behind attention and focus? Take the Precision Peptide Genetic Test.

This article is part of the PlexusDx Education Hub. Browse all Brain & Cognitive Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.